Index
1 Market Overview
1.1 Product Overview and Scope of Genetically Modified Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Genetically Modified Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Transgenic Animal
1.3.3 Transgenic Plant
1.4 Market Analysis by Application
1.4.1 Overview: Global Genetically Modified Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Genetically Modified Drug Market Size & Forecast
1.5.1 Global Genetically Modified Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Genetically Modified Drug Sales Quantity (2018-2029)
1.5.3 Global Genetically Modified Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 LFB Biotechnologies SA
2.1.1 LFB Biotechnologies SA Details
2.1.2 LFB Biotechnologies SA Major Business
2.1.3 LFB Biotechnologies SA Genetically Modified Drug Product and Services
2.1.4 LFB Biotechnologies SA Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 LFB Biotechnologies SA Recent Developments/Updates
2.2 Pharming Group NV
2.2.1 Pharming Group NV Details
2.2.2 Pharming Group NV Major Business
2.2.3 Pharming Group NV Genetically Modified Drug Product and Services
2.2.4 Pharming Group NV Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pharming Group NV Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Genetically Modified Drug Product and Services
2.3.4 Pfizer Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Genetically Modified Drug Product and Services
2.4.4 Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Roche Recent Developments/Updates
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Genetically Modified Drug Product and Services
2.5.4 Abbott Laboratories Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Laboratories Recent Developments/Updates
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Genetically Modified Drug Product and Services
2.6.4 Johnson & Johnson Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Johnson & Johnson Recent Developments/Updates
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business
2.7.3 Merck & Co. Genetically Modified Drug Product and Services
2.7.4 Merck & Co. Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck & Co. Recent Developments/Updates
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Genetically Modified Drug Product and Services
2.8.4 Amgen Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Amgen Recent Developments/Updates
2.9 F. Hoffmann-La Roche
2.9.1 F. Hoffmann-La Roche Details
2.9.2 F. Hoffmann-La Roche Major Business
2.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product and Services
2.9.4 F. Hoffmann-La Roche Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 F. Hoffmann-La Roche Recent Developments/Updates
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Genetically Modified Drug Product and Services
2.10.4 Sanofi Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sanofi Recent Developments/Updates
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Genetically Modified Drug Product and Services
2.11.4 Novartis Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novartis Recent Developments/Updates
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly Genetically Modified Drug Product and Services
2.12.4 Eli Lilly Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Eli Lilly Recent Developments/Updates
2.13 Takeda
2.13.1 Takeda Details
2.13.2 Takeda Major Business
2.13.3 Takeda Genetically Modified Drug Product and Services
2.13.4 Takeda Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Takeda Recent Developments/Updates
2.14 Baxter
2.14.1 Baxter Details
2.14.2 Baxter Major Business
2.14.3 Baxter Genetically Modified Drug Product and Services
2.14.4 Baxter Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Baxter Recent Developments/Updates
2.15 GlaxoSmithKline
2.15.1 GlaxoSmithKline Details
2.15.2 GlaxoSmithKline Major Business
2.15.3 GlaxoSmithKline Genetically Modified Drug Product and Services
2.15.4 GlaxoSmithKline Genetically Modified Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 GlaxoSmithKline Recent Developments/Updates
3 Competitive Environment: Genetically Modified Drug by Manufacturer
3.1 Global Genetically Modified Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Genetically Modified Drug Revenue by Manufacturer (2018-2023)
3.3 Global Genetically Modified Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Genetically Modified Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Genetically Modified Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Genetically Modified Drug Manufacturer Market Share in 2022
3.5 Genetically Modified Drug Market: Overall Company Footprint Analysis
3.5.1 Genetically Modified Drug Market: Region Footprint
3.5.2 Genetically Modified Drug Market: Company Product Type Footprint
3.5.3 Genetically Modified Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Genetically Modified Drug Market Size by Region
4.1.1 Global Genetically Modified Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Genetically Modified Drug Consumption Value by Region (2018-2029)
4.1.3 Global Genetically Modified Drug Average Price by Region (2018-2029)
4.2 North America Genetically Modified Drug Consumption Value (2018-2029)
4.3 Europe Genetically Modified Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Genetically Modified Drug Consumption Value (2018-2029)
4.5 South America Genetically Modified Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Genetically Modified Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Genetically Modified Drug Sales Quantity by Type (2018-2029)
5.2 Global Genetically Modified Drug Consumption Value by Type (2018-2029)
5.3 Global Genetically Modified Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Genetically Modified Drug Sales Quantity by Application (2018-2029)
6.2 Global Genetically Modified Drug Consumption Value by Application (2018-2029)
6.3 Global Genetically Modified Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Genetically Modified Drug Sales Quantity by Type (2018-2029)
7.2 North America Genetically Modified Drug Sales Quantity by Application (2018-2029)
7.3 North America Genetically Modified Drug Market Size by Country
7.3.1 North America Genetically Modified Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Genetically Modified Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Genetically Modified Drug Sales Quantity by Type (2018-2029)
8.2 Europe Genetically Modified Drug Sales Quantity by Application (2018-2029)
8.3 Europe Genetically Modified Drug Market Size by Country
8.3.1 Europe Genetically Modified Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Genetically Modified Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Genetically Modified Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Genetically Modified Drug Market Size by Region
9.3.1 Asia-Pacific Genetically Modified Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Genetically Modified Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Genetically Modified Drug Sales Quantity by Type (2018-2029)
10.2 South America Genetically Modified Drug Sales Quantity by Application (2018-2029)
10.3 South America Genetically Modified Drug Market Size by Country
10.3.1 South America Genetically Modified Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Genetically Modified Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Genetically Modified Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Genetically Modified Drug Market Size by Country
11.3.1 Middle East & Africa Genetically Modified Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Genetically Modified Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Genetically Modified Drug Market Drivers
12.2 Genetically Modified Drug Market Restraints
12.3 Genetically Modified Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Genetically Modified Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Genetically Modified Drug
13.3 Genetically Modified Drug Production Process
13.4 Genetically Modified Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Genetically Modified Drug Typical Distributors
14.3 Genetically Modified Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer